Biosign announces intention to Deliver Non-Invasive Healthcare Monitoring Solution with Mitel

Collaboration intended to Enable Delivery of Remote Patient Management through Mitel IP Phones

TORONTO, Nov. 10 /PRNewswire-FirstCall/ - Biosign Technologies (TSXV: BIO), a novel health monitoring technology company, has announced the intention to deliver its non-invasive healthcare monitoring solution in collaboration with Mitel (NASD: MITL), a leading provider of unified communications software solutions.  The companies have signed a memorandum of understanding to collaborate on a solution intended to enable certain Mitel products to be used as a voice and data communication portal between a patient, a resident, or an employee using the Biosign UFIT® PAD to send their vital data to Biosign's data mining and rendering servers, and then have results sent to the appropriate parties

"Utilizing a single non-invasive device for data collection, a single platform, and a universal virtual network is an extremely powerful combination that customers can seamlessly adopt and deliver across their organization - locally, regionally, nationally or globally," says Radu Leca, President & CEO, Biosign Technologies. "We look forward to working with Mitel to develop a solution aligned with the needs of customers."

The combined solution is intended to help prevent adverse responses to medication, track chronic illnesses such as Diabetes and Hypertension, provide medication reminders and management, and offer remote patient management.

Key markets that could be addressed with a combined solution include assisted living and long term care facilities, workplace wellness programs and people living at home that require chronic disease management tools to assist them in their daily living activities.

About Biosign Technologies Inc.

Biosign Technologies Inc. (TSX-V: BIO) provides biomedical systems. Key applications include intelligent systems for noninvasive monitoring of common health risks associated with blood pressure, glucose, and medication. The core technology combines measurement, analysis, and rapid knowledge formation to support health monitoring across global markets. The UFIT® medical device technology powers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation & management, and remote patient monitoring. For more information on Biosign, please visit http://www.biosign.com  

About Mitel

Mitel Networks (Nasdaq: MITL) is a global provider of business communications solutions and services, consisting of unified communications and collaboration software applications, IP telephony platforms, mobility applications and managed and network services. Mitel enables businesses of all sizes to move beyond basic fixed telephony tools toward integrated multi-media collaboration solutions, accessible from anywhere, helping to improve performance, gain competitive advantage, and reduce costs. Mitel's global headquarters are in Ottawa, Canada, US headquarters are in Chandler, Arizona and EMEA headquarters are in Caldicot, UK, with offices, partners, and resellers worldwide. For more information visit: http://www.mitel.com

Mitel and the Mitel logo are registered trademarks of Mitel Networks Corporation.

All other trademarks are the property of their respective owners.

SOURCE Biosign Technologies Inc.